Mark Sheptoff Financial Planning’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-150
| Closed | -$17K | – | 370 |
|
|
2020
Q3 | $17K | Hold |
150
| – | – | 0.01% | 199 |
|
|
2020
Q2 | $17K | Hold |
150
| – | – | 0.01% | 213 |
|
|
2020
Q1 | $13K | Hold |
150
| – | – | 0.01% | 210 |
|
|
2019
Q4 | $16K | Hold |
150
| – | – | 0.01% | 241 |
|
|
2019
Q3 | $15K | Hold |
150
| – | – | 0.01% | 241 |
|
|
2019
Q2 | $20K | Hold |
150
| – | – | 0.01% | 214 |
|
|
2019
Q1 | $20K | Hold |
150
| – | – | 0.01% | 213 |
|
|
2018
Q4 | $15K | Hold |
150
| – | – | 0.01% | 208 |
|
|
2018
Q3 | $21K | Hold |
150
| – | – | 0.01% | 235 |
|
|
2018
Q2 | $19K | Hold |
150
| – | – | 0.01% | 229 |
|
|
2018
Q1 | $17K | Hold |
150
| – | – | 0.01% | 245 |
|
|
2017
Q4 | $18K | Hold |
150
| – | – | 0.01% | 242 |
|
|
2017
Q3 | $21K | Hold |
150
| – | – | 0.01% | 234 |
|
|
2017
Q2 | $18K | Sell |
150
-1
| -0.7% | -$120 | 0.01% | 237 |
|
|
2017
Q1 | $18K | Buy |
151
+1
| +0.7% | +$119 | 0.01% | 241 |
|
|
2016
Q4 | $18K | Sell |
150
-25
| -14% | -$3K | 0.01% | 228 |
|
|
2016
Q3 | $21K | Hold |
175
| – | – | 0.02% | 213 |
|
|
2016
Q2 | $20K | Sell |
175
-30
| -15% | -$3.43K | 0.01% | 207 |
|
|
2016
Q1 | $29K | Hold |
205
| – | – | 0.02% | 184 |
|
|
2015
Q4 | $39K | Hold |
205
| – | – | 0.03% | 182 |
|
|
2015
Q3 | $32K | Buy |
205
+22
| +12% | +$3.43K | 0.03% | 188 |
|
|
2015
Q2 | $33K | Buy |
183
+8
| +5% | +$1.44K | 0.03% | 195 |
|
|
2015
Q1 | $30K | Hold |
175
| – | – | 0.03% | 195 |
|
|
2014
Q4 | $32K | Hold |
175
| – | – | 0.03% | 195 |
|
|
2014
Q3 | $29K | Hold |
175
| – | – | 0.03% | 202 |
|
|
2014
Q2 | $27K | Hold |
175
| – | – | 0.02% | 207 |
|
|
2014
Q1 | $27K | Buy |
+175
| New | +$27K | 0.02% | 217 |
|